ANIK
Anika Therapeutics Inc
Price:  
11.25 
USD
Volume:  
477,494.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika DCF Valuation - Growth Exit 5Y

-63.4%
Upside

What is the DCF valuation of Anika??

The Discounted Cash Flow (DCF) valuation of Anika Therapeutics Inc (ANIK) is 4.11 USD. With the latest stock price at 11.25 USD, the upside of Anika Therapeutics Inc based on DCF is -63.4%.

Is Anika a buy or a sell?

Based on the latest price of 11.25 USD and our DCF valuation, Anika Therapeutics Inc (ANIK) is a sell. selling Anika stocks now will result in a potential gain of 63.4%.

Range Selected
WACC / Discount Rate 4.7% - 6.4% 5.5%
Long-term Growth Rate 3.0% - 4.4% 3.7%
Fair Price 3.63 - 10.81 4.11
Upside -67.7% - -3.9% -63.4%
11.25 USD
Stock Price
4.11 USD
Fair Price